Table 1

Clinical sample demographics for MR-seq data generation

CaseNumber of regionsRegion detailsAge (years)GenderComment
CRC16Three primary, two LN met, one liver met53FemaleMSS; KRAS mutant
CRC210Three primary, three LN met, omental met, two liver met44MaleMSS
UBC8Three primary, three ureteral mass, three LN met80Male
RCC9Three primary, three IVC, three liver met62FemaleIVC tumor thrombus
NSCLC12Three primary, three chest wall met, two+four‚ÄČLN met66Male
  • CRC, colorectal adenocarcinoma; IVC, inferior vena cava; KRAS, Kirsten RAS oncogene; LN, lymph node; MR-seq, multiregion sequencing; MSS, Microsatellite stable; NSCLC, non-small cell lung carcinoma; RCC, renal cell carcinoma; UBC, urothelial bladder carcinoma.